Altered expression of transcription factors NKX6-2 and RUNX3, relative to controls, further emphasizes transcription as a central pathological mechanism in ALS-TD patients (Fig. S11; Supplementary Data 10). This evidence concerns the gene NKX6-2 and thanatophoric dysplasia.